Beneficial effects of physical exercise and an orally active mGluR2/3 antagonist pro-drug on neurogenesis and behavior in an Alzheimer's amyloidosis model.

Saved in:
Bibliographic Details
Title: Beneficial effects of physical exercise and an orally active mGluR2/3 antagonist pro-drug on neurogenesis and behavior in an Alzheimer's amyloidosis model.
Authors: Perez Garcia G; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States., Bicak M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Buros J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Haure-Mirande JV; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Perez GM; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States., Otero-Pagan A; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States., Gama Sosa MA; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., De Gasperi R; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Sano M; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Gage FH; Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, United States.; BrainCells, Inc., La Jolla, CA, United States., Barlow C; BrainCells, Inc., La Jolla, CA, United States.; E-Scape Bio, South San Francisco, CA, United States., Dudley JT; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Glicksberg BS; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Wang Y; Department of Developmental and Cell Biology, University of Michigan, Ann Arbor, MI, United States., Readhead B; Arizona State University-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, AZ, United States., Ehrlich ME; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Elder GA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Neurology Service, James J. Peters Department of Veterans Affairs Medical Center, Bronx, NY, United States., Gandy S; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Research and Development, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.; Department of Psychiatry and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Mount Sinai Center for Cognitive Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Source: Frontiers in dementia [Front Dement] 2023 Sep 06; Vol. 2, pp. 1198006. Date of Electronic Publication: 2023 Sep 06 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918787575706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-3919 (Electronic) Linking ISSN: 28133919 NLM ISO Abbreviation: Front Dement Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2813-3919
DOI:10.3389/frdem.2023.1198006